☆ 4.5 Article

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients

Linda Petrone et al.

Summary: The study showed that specific T cell responses to SARS CoV 2 peptides can be detected in COVID-19 patients and are significantly different from individuals without COVID-19. This immune response exhibits characteristics of both Th1 and Th2 profiles, potentially serving as a new T cell-based diagnostic tool.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Review Immunology

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game

Jean-Louis Palgen et al.

Summary: Optimizing vaccination strategies involves understanding how vaccine history affects memory B and T cell characteristics. Innate cells, particularly myeloid lineage cells, respond differently to first and second vaccine doses, affecting innate immune responses. Trained innate cells have the potential to improve vaccination strategies by enhancing antigen uptake, presentation, migration, and cytokine production.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Surgery

COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination

Hani M. Wadei et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

Yael Peled et al.

Summary: The study investigated the safety and efficacy of BNT162b2 vaccine in heart transplant recipients, showing a low rate of adverse events and some individuals developing antibody responses. The presence of IgG anti-RBD antibodies was associated with neutralizing SARS-CoV-2 pseudo-virus, but certain immunosuppressive regimens may impact the odds of an antibody response. Further research is needed to determine the optimal observation period for antibody response in immunocompromised individuals.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 vaccination immune paresis in heart and lung transplantation

Saima Aslam et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Shilong Yang et al.

Summary: The results from Phase 1 and Phase 2 trials of the COVID-19 vaccine ZF2001 show that the vaccine is well tolerated and immunogenic, supporting the use of a 25 microgram dose in a three-dose schedule for large-scale evaluation in a Phase 3 trial.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri et al.

Summary: The study reveals that antibody responses to SARS-CoV-2 spike protein play a significant role in neutralization and protection against severe COVID-19, unaffected by heterologous boosting or common cold immunity, and can last for up to 8 months.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Letter Medicine, General & Internal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William A. Werbel et al.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

Jan Havlin et al.

Summary: Transplant recipients showed weaker antibody response to mRNA COVID-19 vaccine compared to natural infection, with only a subset of patients demonstrating SARS-CoV-2 specific T-cell response. Further research is needed to identify the optimal vaccine type and schedule for immunocompromised transplant patients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Tina Schmidt et al.

Summary: In healthy adults, vaccination with an mRNA vaccine as a booster, regardless of the initial vaccine, resulted in higher levels of spike-specific antibodies and T cells compared to booster vaccination with ChAdOx1 nCov-19. Heterologous vaccination with ChAdOx1 nCoV-19 followed by an mRNA vaccine induced strong immune responses with acceptable reactogenicity, showing similar or better effects than homologous mRNA vaccine regimens.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination

Johan Normark et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

Venkata-Viswanadh Edara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Immunology

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Nicole M. Ali et al.

TRANSPLANTATION (2021)

添加到收藏夹

Article Immunology

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Jialu Zhang et al.

Summary: The study found significant differences in humoral and cellular immune responses induced by different vaccine platforms when administered individually in a mouse model. Boosting with recombinant subunit, adenovirus vectored or mRNA vaccine after two doses of inactivated vaccine improved immune responses compared to a third dose of inactivated vaccine. This provides new ideas for prophylactic vaccination strategy against SARS-CoV-2.

EMERGING MICROBES & INFECTIONS (2021)

添加到收藏夹

Article Microbiology

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition

M. Eugenia Dieterle et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis

Victoria Indenbaum et al.

PLOS ONE (2020)

添加到收藏夹

Article Surgery

Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice

Lara Danziger-Isakov et al.

CLINICAL TRANSPLANTATION (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Metformin therapy reduces the risk of malignancy after heart transplantation

Yael Peled et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)

添加到收藏夹

Article Immunology

Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents

Chris P. Verschoor et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.